Schedule Appointment

Center for Prostate Cancer

Our experience and specialized expertise enables us to provide unparalleled seamless care for prostate cancer patients.

Schedule Appointment

Dr. Ash Tewari

Dr. Ash Tewari is Professor and Chairman of Urology at the Icahn School of Medicine at Mount Sinai. He leads of team of professionals driven by a passion to provide unparalleled patient care.

Dr. Ash Tewari is one of the world’s leading researchers and surgeons in the field of prostate cancer. He specializes in robotic prostatectomy and has performed over 5,500 cases. Utilizing an array of innovative techniques, like robotic prostatectomy, that he has pioneered, published in prestigious peer reviewed medical journals, his treatment offers a cure for a majority of prostate cancer patients.

Dr. Tewari is the 2012 recipient of the American Urological Association Gold Cystoscope Award. He was the first to identify the nerves responsible for erectile function as a neural hammock. This increased understanding of the prostate anatomy aids in nerve-sparing prostate surgery techniques for robotic prostatectomy. As an active researcher, he is one of only a few robotic surgeons to be awarded a NIH R01 grant. This funding is for the investigation of real-time tissue identification during prostate cancer surgery.

LEARN MORE

 

ART™ (Advanced Robotic Technique) prostatectomy is a term that encompasses the robotic surgical techniques developed by Dr. Ash Tewari and his team.

 

Learn More
In a pursuit to achieve balance between early detection, prevention of overtreatment and monitoring of disease progression, active surveillance (AS) has emerged as a viable option for patients with low risk, low volume prostate cancer.Learn More
At Mount Sinai, our Precision Urology™ approach to diagnosing prostate cancer involves the integration of multiple variables and imaging data in a decision support system.Learn More
By fusing multiparametric MRI with real-time ultrasound, abnormal or suspicious areas seen on the MRI can be tracked and targeted during a prostate biopsy.Learn More

ART™ Advanced Robotic Technique

The robotic prostate surgery approach used by Dr. Tewari is known as ART™ (Advanced Robotic Technique) prostatectomy, or ART™ for short. It is a highly successful approach to curing prostate cancer while minimizing side effects in select patients. Dr. Tewari and his team have developed and refined ART™ over the past decade based on the thousands of surgeries they have performed, their discoveries in prostate anatomy, and other leading-edge research. ART™ is highly individualized, reflecting a patient’s unique anatomy, cancer location and neural structure. Indeed, for Dr. Tewari, ART™ is truly an art. He routinely makes anatomical drawings of prostates on which he operates in order to map out a cancer’s spatial relationships to the fascia, muscles and nerves that surround the prostate. By drawing the anatomy of individual cases, he continues to fine tune ART ™ and improve cancer control while sparing nerves. He also uses the drawings as a teaching tool for students as well as his peers worldwide who are eager to learn his technique. The crux of the ART™ technique is the delicate removal of the prostate from the top of the nerve hammock with maximal clearance for preserving sexual and urinary function. Not only are nerves not handled, but oxygenation of the nerves is monitored during this phase of the technique so these preserved nerves are greater in number and also healthy and vascular.

LEARN MORE

 

Video Gallery

VIEW MORE

Active Surveillance

Prostate cancer remains a major public health concern for men in the United States and the Western world, with about 200,000 men being diagnosed with prostate cancer and around 30,000 men dying from it in annually in the United States alone. In the last decade, use of serum prostate specific antigen (PSA) screening have led to more men being diagnosed earlier with prostate cancer that is curable and at times biologically confined to the prostate. A few of these men diagnosed with prostate cancer are found to have what is deemed to be low risk disease, defined as PSA 10ng/ml or less, biopsy Gleason score 6 or less, and clinical stage T2a or less. For these low risk low volume Gleason 6 patients, active surveillance (AS) is becoming an increasingly popular alternative to definitive treatment modalities such as radiation and surgery. It seeks to avoid the morbidity associated with overtreatment of indolent prostate cancer, and delay treatment for disease until it becomes clinically significant.

LEARN MORE

Precision Urology™

Precise MD

Personalized prediction of tumor response and cancer progression on prostate needle biopsy using quantitative biometric featuresLEARN MORE

Fusion Biopsies

By fusing multiparametric MRI with real-time ultrasound, abnormal or suspicious areas seen on the MRI can be tracked and targeted during a prostate biopsy. LEARN MORE

3Tesla Multiparametric MRI

3 Tesla Multiparametric Magnetic Resonance Imaging is a state of the art, non-invasive imaging modality that facilitates diagnosing, staging and pre-operative planning for prostate cancer.LEARN MORE

Genetic Analysis

Genetic screening can pick up mutations in an individual’s genetic code that may increase the risk of advanced prostate cancer.LEARN MORE

da Vinci Robot

The daVinci Surgical System is a sophisticated robotic platform designed to expand the surgeon’s capabilities.LEARN MORE

NeuroSAFE

NeuroSAFE allows the assessment of surgical margin for absence or presence of cancer intra-operatively.LEARN MORE

Our Physicians

OUR RESEARCH

Patient Information

New Prostate Cancer Patients

Are you a new prostate cancer patient? Get in touch with our experts to handle your clinical care.LEARN MORE

Insurance Information

Find information about accepted insurance

 

LEARN MORE

Post-Surgical Patients

Find information about post-surgical follow-up schedule and care

 

LEARN MORE

Biopsy Patients

Find information on how to prepare for your biopsy and what to expect after.LEARN MORE

International Patients

International patients interested in prostate cancer care or MRI fusion biopsy.LEARN MORE.

Referring Physicians

Find information about transferring patients and continuity of care.LEARN MORE